» Articles » PMID: 16942034

Effect of Lysine at C-terminus of the Dmt-Tic Opioid Pharmacophore

Overview
Journal J Med Chem
Specialty Chemistry
Date 2006 Sep 1
PMID 16942034
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Substitution of Gly with side-chain-protected or unprotected Lys in lead compounds containing the opioid pharmacophore Dmt-Tic [H-Dmt-Tic-Gly-NH-CH(2)-Ph, mu agonist/delta antagonist; H-Dmt-Tic-Gly-NH-Ph, mu agonist/delta agonist; and H-Dmt-Tic-NH-CH(2)-Bid, delta agonist (Bid = 1H-benzimidazole-2-yl)] yielded a new series of compounds endowed with distinct pharmacological activities. Compounds (1-10) included high delta- (Ki(delta) = 0.068-0.64 nM) and mu-opioid affinities (Ki(mu) = 0.13-5.50 nM), with a bioactivity that ranged from mu-opioid agonism {10, H-Dmt-Tic-NH-CH[(CH2)4-NH2]-Bid (IC50 GPI = 39.7 nM)} to a selective mu-opioid antagonist [3, H-Dmt-Tic-Lys-NH-CH2-Ph (pA2(mu) = 7.96)] and a selective delta-opioid antagonist [5, H-Dmt-Tic-Lys(Ac)-NH-Ph (pA2(delta) = 12.0)]. The presence of a Lys linker provides new lead compounds in the formation of opioid peptidomimetics containing the Dmt-Tic pharmacophore with distinct agonist and/or antagonist properties.

Citing Articles

Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells.

Cai B, El Daibani A, Bai Y, Che T, Krusemark C JACS Au. 2023; 3(4):1076-1088.

PMID: 37124302 PMC: 10131204. DOI: 10.1021/jacsau.2c00674.


Selection of DNA-Encoded Libraries to Protein Targets within and on Living Cells.

Cai B, Kim D, Akhand S, Sun Y, Cassell R, Alpsoy A J Am Chem Soc. 2019; 141(43):17057-17061.

PMID: 31613623 PMC: 7057806. DOI: 10.1021/jacs.9b08085.


A DFT and semiempirical model-based study of opioid receptor affinity and selectivity in a group of molecules with a morphine structural core.

Bruna-Larenas T, Gomez-Jeria J Int J Med Chem. 2014; 2012:682495.

PMID: 25379287 PMC: 4207423. DOI: 10.1155/2012/682495.


Engineering endomorphin drugs: state of the art.

Lazarus L, Okada Y Expert Opin Ther Pat. 2012; 22(1):1-14.

PMID: 22214283 PMC: 3253703. DOI: 10.1517/13543776.2012.646261.


Current research on opioid receptor function.

Feng Y, He X, Yang Y, Chao D, Lazarus L, Xia Y Curr Drug Targets. 2011; 13(2):230-46.

PMID: 22204322 PMC: 3371376. DOI: 10.2174/138945012799201612.


References
1.
Salvadori S, Guerrini R, Balboni G, Bianchi C, Bryant S, Cooper P . Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. J Med Chem. 1999; 42(24):5010-9. DOI: 10.1021/jm990165m. View

2.
Vazquez M, Blanco J, Salvadori S, Trapella C, Argazzi R, Bryant S . 6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. J Med Chem. 2006; 49(12):3653-8. PMC: 1994907. DOI: 10.1021/jm060343t. View

3.
Balboni G, Salvadori S, Guerrini R, Bianchi C, Santagada V, Calliendo G . Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei. Peptides. 2000; 21(11):1663-71. DOI: 10.1016/s0196-9781(00)00315-6. View

4.
Hall F, Sora I, Uhl G . Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl). 2001; 154(1):43-9. DOI: 10.1007/s002130000622. View

5.
Krystal J, Cramer J, KROL W, Kirk G, Rosenheck R . Naltrexone in the treatment of alcohol dependence. N Engl J Med. 2001; 345(24):1734-9. DOI: 10.1056/NEJMoa011127. View